We started clinical application of using?stem cell transplantation to treat diabetes since our department’s clinical trial registration was approved by the WHO in April, 2010. (Registration number of stem cell transplantation to treat type 1 diabetes: ChiCTR-TNC-10000986; registration number of stem cell transplantation to treat type 2?diabetes: ChiCTR-ONC-10000985).
Till the end of 2016, our department treated more than 508?patients of type 2 diabetes, and the treatment is effective to over 93% of patients, and 60% of patients have a better blood glucose control with half dose of the insulin than before. After the first course of treatment, 30% of patients can stop using insulin and oral hypoglycemic drugs.
Based on our clinical experience and data, if the patient has a better improvement in glycemic control and complications after the first course of treatment, it is recommended that the patient receive a second course of treatment after 6 months to achieve a consistently stable improvement. Clinically, the treatment methods of intravenous infusion and vascular intervention are mainly used. Today, more and more patients, including foreigners, are receiving treatment.


Possible improvements after treatment mainly on:

● Reduce or eliminate dependence on drugs such as insulin, hypoglycemic agents, etc.
● Improve vision
● Adjusting fasting blood glucose
● Improve blood circulation in the extremities
● Improve abnormal feelings such as numbness and pain in the limbs
● Improve immunity and fatigue

57 years old

36 years old

51 years old

About Us

The Stem Cell Department of General hospital of Chinese People’s Armed Police Forces is the first neural stem cell transplantation centre in China, which went through the World Health Organisation (WHO) clinical trial registration. The Hospital has also obtained the FDA clinical trial approval and had our laboratory certified with Good Manufacturing Procedures (GMP) certification of stem cell research and preparation. So far we have used stem cell therapy to treat 16,000+ patients from more than 30 countries.

Why choose us

Our department is the first nerve stem cell transplantation center in the country and abroad, which has passed through the WHO clinical registration test, received FDA approval of a clinical trial and was certified by the laboratory with the GMP standard of research. So far, we have already treated about 16,000+ patients from more than 30 countries with stem cell transplantation.

Contact us

Address: YongDing Road 69#, Haidian District, Beijing

Telephoe: +86 10 56259395

E-mail: cs1@thebrightdirection.com

Connect with us

Invalid Input

Invalid Input

Invalid Input